QLT, Inc. (USA) (NASDAQ:QLTI)

CAPS Rating: 3 out of 5

A biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies.

Recs

0
Player Avatar jsgant13 (97.73) Submitted: 8/4/2010 8:19:05 AM : Outperform Start Price: $5.67 QLTI Score: +16.30

following Eliav Assouline and Marc Andersen's hedge fund Axial Capital Management

Report this Post Reply

Featured Broker Partners


Advertisement